Analyst firms · Barclays · PHR
Barclays PHR price target and rating history
Phreesia Inc. (PHR) · Consumer Discretionary
Barclays rates Phreesia Inc. (PHR) Equal Weight with a $10 price target, as of its latest action on May 15, 2026. It has published 3 rating actions on PHR since January 2024, including 0 upgrades and 1 downgrade. Across 8 firms with a PHR price target in the last 12 months, the median target is $10.50. Barclays's $10 is 5% below that.
- Current rating
- Equal Weight
- Price target
- $10
- Median target, all firms
- $10.50
- Actions on PHR
- 3
Barclays price target on PHR
Every Barclays rating on PHR
- May 15, 2026
- Dec 9, 2025
- Jan 3, 2024
How other firms rate PHR
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Raymond James | Mkt Perform | Sep 8, 2026 | |
| Piper Sandler | Neutral | $12 | May 28, 2026 |
| Wells Fargo | Equal Weight | $9 | May 20, 2026 |
| Barclays | Equal Weight | $10 | May 15, 2026 |
| Citizens JMP | Mkt Perform | Apr 1, 2026 | |
| Robert W. Baird | Neutral | $10 | Mar 31, 2026 |
| Truist Securities | Hold | $11 | Mar 31, 2026 |
| Citigroup | Neutral | $10 | Mar 31, 2026 |
| Needham | Buy | $14 | Mar 31, 2026 |
| RBC Capital Markets | Outperform | $26 | Jan 9, 2026 |
Questions about Barclays and PHR
- What is Barclays's price target for PHR?
- Barclays's latest stated price target for Phreesia Inc. (PHR) is $10, from its action on May 15, 2026.
- What is Barclays's rating on PHR?
- Barclays rates PHR Equal Weight, a neutral rating, as of May 15, 2026.
- When did Barclays last change its view on PHR?
- On May 15, 2026, Barclays downgrades to Equal Weight from Overweight, price target $10.
- How does Barclays's PHR target compare with other analysts?
- Across 8 firms with a PHR price target in the last 12 months, the median target is $10.50. Barclays's $10 is 5% below that.
More PHR rating histories
All Barclays ratingsPHR news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.